Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 2
1953 3
1954 7
1955 9
1956 5
1957 8
1958 9
1959 4
1960 5
1961 11
1962 16
1963 14
1964 15
1965 22
1966 24
1967 38
1968 29
1969 23
1970 40
1971 25
1972 29
1973 21
1974 28
1975 34
1976 36
1977 39
1978 42
1979 41
1980 53
1981 55
1982 53
1983 68
1984 83
1985 94
1986 95
1987 106
1988 113
1989 116
1990 127
1991 118
1992 151
1993 172
1994 153
1995 181
1996 215
1997 207
1998 216
1999 238
2000 270
2001 245
2002 238
2003 221
2004 235
2005 267
2006 249
2007 254
2008 301
2009 278
2010 289
2011 284
2012 354
2013 398
2014 378
2015 413
2016 399
2017 443
2018 432
2019 449
2020 525
2021 573
2022 540
2023 507
2024 447
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,136 results

Results by year

Filters applied: . Clear all
Page 1
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Among authors: nakamura s. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.
Next questions in autophagy.
Cuervo AM, Elazar Z, Evans C, Ge L, Hansen M, Jäättelä M, Liang JRA, Loos B, Mizushima N, Simon AK, Tooze S, Yoshimori T, Nakamura S. Cuervo AM, et al. Among authors: nakamura s. Nat Cell Biol. 2024 May;26(5):661-666. doi: 10.1038/s41556-024-01404-z. Nat Cell Biol. 2024. PMID: 38641661 No abstract available.
MicroRNA-34a-5p Promotes Joint Destruction During Osteoarthritis.
Endisha H, Datta P, Sharma A, Nakamura S, Rossomacha E, Younan C, Ali SA, Tavallaee G, Lively S, Potla P, Shestopaloff K, Rockel JS, Krawetz R, Mahomed NN, Jurisica I, Gandhi R, Kapoor M. Endisha H, et al. Among authors: nakamura s. Arthritis Rheumatol. 2021 Mar;73(3):426-439. doi: 10.1002/art.41552. Epub 2021 Feb 8. Arthritis Rheumatol. 2021. PMID: 33034147 Free PMC article.
Analysis of gut microbiome, host genetics, and plasma metabolites reveals gut microbiome-host interactions in the Japanese population.
Tomofuji Y, Kishikawa T, Sonehara K, Maeda Y, Ogawa K, Kawabata S, Oguro-Igashira E, Okuno T, Nii T, Kinoshita M, Takagaki M, Yamamoto K, Arase N, Yagita-Sakamaki M, Hosokawa A, Motooka D, Matsumoto Y, Matsuoka H, Yoshimura M, Ohshima S, Nakamura S, Fujimoto M, Inohara H, Kishima H, Mochizuki H, Takeda K, Kumanogoh A, Okada Y. Tomofuji Y, et al. Among authors: nakamura s. Cell Rep. 2023 Nov 28;42(11):113324. doi: 10.1016/j.celrep.2023.113324. Epub 2023 Nov 6. Cell Rep. 2023. PMID: 37935197 Free article.
Spirochete Flagella and Motility.
Nakamura S. Nakamura S. Biomolecules. 2020 Apr 4;10(4):550. doi: 10.3390/biom10040550. Biomolecules. 2020. PMID: 32260454 Free PMC article. Review.
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Shimada K, et al. Among authors: nakamura s. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171071 Clinical Trial.
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K, Sugiyama S, Sumida H, Shimomura H, Yamashita T, Yamanaga K, Komura N, Sakamoto K, Oka H, Nakao K, Nakamura S, Ishihara M, Matsui K, Sakaino N, Nakamura N, Yamamoto N, Koide S, Matsumura T, Fujimoto K, Tsunoda R, Morikami Y, Matsuyama K, Oshima S, Kaikita K, Hokimoto S, Ogawa H; PRECISE–IVUS Investigators. Tsujita K, et al. Among authors: nakamura s. J Am Coll Cardiol. 2015 Aug 4;66(5):495-507. doi: 10.1016/j.jacc.2015.05.065. J Am Coll Cardiol. 2015. PMID: 26227186 Free article. Clinical Trial.
11,136 results
You have reached the last available page of results. Please see the User Guide for more information.